AllPennyStocks.com OCUL, FDMT Stock Clock Best Day In Weeks After EyePoint’s Trial Setback — Here’s Why
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

OCUL, FDMT Stock Clock Best Day In Weeks After EyePoint’s Trial Setback — Here’s Why

EyePoint Pharmaceuticals said on Monday that its late-stage trial of DURAVYU, an experimental long-lasting eye implant for wet age-related macular degeneration, missed its main goal.

Other Penny Stock Movers

Sub-Dollar Cancer Diagnostics Play Erupts on Q2 Revenue
Completion of 1,800m Maiden Program Sparks 14% Surge for BC Porphyry Developer
Arizona Copper Jumps Explorer Jumps 32% as Soil Sampling Outlines Large Arizona Porphyry System
Most Popular
{{ index + 1 }}


Back to Top